WAUKESHA, WI (February 12, 2007) – Prodesse, Inc. announced today that several leading healthcare institutions have begun clinical trials of its recently developed ProFlu+, a multiplex PCR assay for the detection and differentiation of Influenza A virus, Influenza B virus and Respiratory Syncytial Virus (RSV). Prodesse has worked closely with the FDA on the clinical study design and expects to submit its application for 510(k) clearance shortly after completion of clinical trials this spring.
